ILOPROST - search results

ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

adempas

bayer ag - riociguat - hipertensión, pulmonar - antihipertensivos para la hipertensión arterial pulmonar - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. la eficacia se ha demostrado en un pah la población, incluyendo a las etiologías de la idiopático o hereditario hap o pah asociada con enfermedad del tejido conectivo. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

revasc

canyon pharmaceuticals ltd. - desirudin - trombosis venosa - agentes antitrombóticos - prevención de la trombosis venosa profunda en pacientes sometidos a cirugía electiva de reemplazo de cadera o rodilla.

ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

volibris

glaxosmithkline (ireland) limited - ambrisentan - hipertensión, pulmonar - los antihipertensivos,los - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bosentan amneal 125 mg comprimidos recubiertos con pelicula efg

amneal pharma europe limited - bosentan monohidrato - excipientes: almidon de maiz,almidon pregelatinizado,dibehenato de glicerol - otros antihipertensivos - otros antihipertensivos - bosentano

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bosentan amneal 62,5 mg comprimidos recubiertos con pelicula efg

amneal pharma europe limited - bosentan monohidrato - excipientes: almidon de maiz,almidon pregelatinizado,dibehenato de glicerol - otros antihipertensivos - otros antihipertensivos - bosentano

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sildenafilo normon 20 mg comprimidos recubiertos con pelicula efg

laboratorios normon s.a. - sildenafilo citrato - comprimido recubierto con pelÍcula - 20 mg - sildenafilo citrato 20 mg - sildenafilo